Trial intelligence / Profile preview

Analgesic effect of erector spinae plane block vs wound infiltration after lumbar fusion surgery

ChiCTR2500114714Phase 4Not yet recruiting

Sponsor
Peking Union Medical College Hospital
Start
Dec 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of bupivacaine in lumbar spinal stenosis (LSS) and lumbar spondylolisthesis (2 arms), sponsored by Peking Union Medical College Hospital. Primary endpoints: Physical Activity VAS Score at 24 hours postoperatively and Cumulative opioid consumption 72h postoperatively. Planned start Dec 2025; status: not yet recruiting.

02

Drugs

bupivacaine
03

Conditions

lumbar spinal stenosis (LSS)lumbar spondylolisthesis

Beyond the preview

Go deeper on ChiCTR2500114714.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2500114714.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call